InvestorsHub Logo

loanranger

04/27/24 10:29 AM

#402615 RE: frenchbroad #402612

Same questions:
Where's Leo?
"The Brazil team is busy."
"The Israel team remain in schedule to ask USA FDA early June for approvals to sell their new system."

You make things sound good. Seems an odd time for a CEO to disappear without a trace, doesn't it?

What will it take for you to stop dispensing hope where none is warranted?

zandant

04/27/24 10:38 AM

#402616 RE: frenchbroad #402612

So why isn't Ehrlich, the CEO of this mess, blowing the Brilacidin horn in the same manner? IPIX is like a ship without a captain or crew. Million dollar negative judgements, no cash, no board, no communication, no press releases in almost a year, no filings, not even on the Pink Sheets anymore, having fallen into this Expert quagmire, a cobwebbed website so full of lies and misinformation that it should be removed. Ehrlich tried to get partners for B to no avail. Alfasigma abandoned its efforts with B. If its so great, why are there no takers? Big pharma, even little pharma, certainly know more than you. You keep posting this type of info as the company descends into darkness and the price hits a 52 week low. Your IPIX portfolio must be a disaster. Misery does not need company.

MackG

04/27/24 1:49 PM

#402619 RE: frenchbroad #402612

Thanks for sharing that information that contradicts the often repeated falsehood that the company is "dead." My favorite part is "Brilicidin alone was shown to inhibit the growth of C. neoformans, acting as a fungicidal drug at concentrations of 2.5 µM, but surprisingly also potentiated the activity of CAS against this species. We have demonstrated that BRI is potentially an important antifungal agent against cryptococcosis, particularly important for synergizing with CAS, which is otherwise ineffective against this pathogen."
https://www.biorxiv.org/content/10.1101/2024.04.10.588976v1.full